- Conditions
- HIV, Frailty, Prefrail, Aging Problems
- Interventions
- Dasatinib, Quercetin, Placebo - Dasatinib, Placebo - Quercetin
- Drug · Other
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 50 Years and older
- Enrollment
- 82 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 26
- States / cities
- Los Angeles, California • San Diego, California • San Francisco, California + 20 more
Source: ClinicalTrials.gov public record
Updated May 18, 2026 · Synced May 21, 2026, 9:46 PM EDT